Predictive Oncology Inc.
POAI
$0.95
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 38.55% | 32.91% | 11.56% | 28.74% | 43.71% |
| Total Depreciation and Amortization | 10.21% | 5.23% | -5.82% | 9.99% | -23.66% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -130.73% | 94.66% | -28.82% | -85.45% | -85.85% |
| Change in Net Operating Assets | -19.97% | -99.06% | 36.02% | -163.05% | -118.28% |
| Cash from Operations | 51.42% | 53.54% | 33.41% | 27.17% | 0.95% |
| Capital Expenditure | -100.00% | 100.00% | 98.86% | 103.70% | 102.68% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4,351.70% | 5,297.48% | 80.99% | 53.48% | 68.66% |
| Cash from Investing | 10,345.90% | 339.08% | 96.86% | 99.41% | 98.81% |
| Total Debt Issued | -4.03% | -- | -- | -- | -- |
| Total Debt Repaid | 24.75% | -5.22% | -215.30% | -- | -- |
| Issuance of Common Stock | -14.35% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | 93.64% | 94.57% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 64.66% | -- | -- | -- | -- |
| Cash from Financing | -10.74% | 15,415.07% | 1,948.96% | 1,225.19% | 12,402.90% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 72.72% | 101.18% | 56.97% | 51.16% | 30.06% |